Bruker, Billerica, Mass., announces recent orders for its Avance ultrahigh-field nuclear magnetic resonance spectroscopy systems from several universities across the United Kingdom. The orders include two 1 GHz NMR systems for the University of Warwick and for the University of Birmingham. The orders also include CryoProbes and Avance NEO console upgrades to existing 800 and 950 MHz systems at several universities across the United Kingdom.
The funding was provided by the Engineering and Physical Sciences Research Council, in collaboration with the Biotechnology and Biological Sciences Research Council, the Medical Research Council, and the Natural Environment Research Council. These councils also form part of UK Research & Innovation.
The University of Warwick has ordered an Avance 1.0 GHz solid-state NMR spectrometer which will provide new structural and dynamic information in chemistry, materials science and biology, and adds to Warwick’s capabilities that include an AVANCE 850 MHz solid-state spectrometer. The new 1 GHz will enable researches from across the UK to be trained with the most advanced equipment. Crucial industrial research in sectors such as pharmaceuticals and catalysis will also benefit from this investment.
The University of Birmingham will focus their future 1 GHz NMR spectrometer on biomedical applications, and to develop new analytical methods for drug discovery and development. Professor Ulrich Guenther added: “The 1 GHz technology will be a crucial step-change for the UK NMR community by providing a tool to study the most challenging problems in structure and behavior of molecules across chemical and biomedical sciences, including real-time measurements of metabolism in cancer cells.”
